These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36016303)

  • 41. The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.
    Zhang B; Chen W; Roman A
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):437-42. PubMed ID: 16381817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development.
    Mansour M; Touka M; Hasan U; Bellopede A; Smet A; Accardi R; Gabet AS; Sylla BS; Tommasino M
    Virology; 2007 Oct; 367(1):1-9. PubMed ID: 17568647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
    Hatterschide J; Brantly AC; Grace M; Munger K; White EA
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein.
    Jones RE; Wegrzyn RJ; Patrick DR; Balishin NL; Vuocolo GA; Riemen MW; Defeo-Jones D; Garsky VM; Heimbrook DC; Oliff A
    J Biol Chem; 1990 Aug; 265(22):12782-5. PubMed ID: 2198278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of low-abundance species in the active pharmaceutical ingredient of CIGB-300: A clinical-grade anticancer synthetic peptide.
    Garay H; Espinosa LA; Perera Y; Sánchez A; Diago D; Perea SE; Besada V; Reyes O; González LJ
    J Pept Sci; 2018 Jun; 24(6):e3081. PubMed ID: 29676523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.
    Ferenczi A; Gyöngyösi E; Szalmás A; László B; Kónya J; Veress G
    Infect Genet Evol; 2016 Sep; 43():94-100. PubMed ID: 27197052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.
    Gonzalez SL; Stremlau M; He X; Basile JR; Münger K
    J Virol; 2001 Aug; 75(16):7583-91. PubMed ID: 11462030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
    Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
    Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The HPV-18 E7 CKII phospho acceptor site is required for maintaining the transformed phenotype of cervical tumour-derived cells.
    Basukala O; Mittal S; Massimi P; Bestagno M; Banks L
    PLoS Pathog; 2019 May; 15(5):e1007769. PubMed ID: 31116803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Reverse Structure-based Design of HPV E7 Inhibitor.
    Tan WC; Othman S; Lim SK; Rashid NN; Heh CH
    Curr Comput Aided Drug Des; 2022; 18(4):318-325. PubMed ID: 35538818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
    Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elucidation of rutin's role in inducing caspase-dependent apoptosis via HPV-E6 and E7 down-regulation in cervical cancer HeLa cells.
    Pandey P; Khan F; Farhan M; Jafri A
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34109976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells.
    Helt AM; Funk JO; Galloway DA
    J Virol; 2002 Oct; 76(20):10559-68. PubMed ID: 12239337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block.
    Nor Rashid N; Yong ZL; Yusof R; Watson RJ
    Virol J; 2016 Jan; 13():2. PubMed ID: 26728921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CIGB-300: A peptide-based drug that impairs the Protein Kinase CK2-mediated phosphorylation.
    Perea SE; Baladrón I; Valenzuela C; Perera Y
    Semin Oncol; 2018 Jan; 45(1-2):58-67. PubMed ID: 30318085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.
    Huh K; Zhou X; Hayakawa H; Cho JY; Libermann TA; Jin J; Harper JW; Munger K
    J Virol; 2007 Sep; 81(18):9737-47. PubMed ID: 17609271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of the binding affinity of different human papillomavirus E7 proteins for the tumour suppressor pRb by a plate-binding assay.
    Dong WL; Caldeira S; Sehr P; Pawlita M; Tommasino M
    J Virol Methods; 2001 Oct; 98(1):91-8. PubMed ID: 11543887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor.
    Liu X; Clements A; Zhao K; Marmorstein R
    J Biol Chem; 2006 Jan; 281(1):578-86. PubMed ID: 16249186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A naturally occurring variant of HPV-16 E7 exerts increased transforming activity through acquisition of an additional phospho-acceptor site.
    Zine El Abidine A; Tomaić V; Bel Haj Rhouma R; Massimi P; Guizani I; Boubaker S; Ennaifer E; Banks L
    Virology; 2017 Jan; 500():218-225. PubMed ID: 27829177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.